Export 199 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N. Acosta-Baena, Lopera-Gómez, C. M., Jaramillo-Elorza, M. C., Velilla-Jiménez, L., Villegas-Lanau, C. Andrés, Sepúlveda-Falla, D., Arcos-Burgos, M., and Lopera, F., Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease., J Alzheimers Dis, 2023.
C. Agyemang, van de Vorst, I. E., Koek, H. L., Bots, M. L., Seixas, A., Norredam, M., Ikram, U., Stronks, K., and Vaartjes, I., Ethnic Variations in Prognosis of Patients with Dementia: A Prospective Nationwide Registry Linkage Study in The Netherlands., J Alzheimers Dis, vol. 56, no. 1, pp. 205-213, 2017.
B. Ahlemeyer, Halupczok, S., Rodenberg-Frank, E., Valerius, K. - P., and Baumgart-Vogt, E., Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation., J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
P. Almeida-Meza, Steptoe, A., and Cadar, D., Is Engagement in Intellectual and Social Leisure Activities Protective Against Dementia Risk? Evidence from the English Longitudinal Study of Ageing., J Alzheimers Dis, vol. 80, no. 2, pp. 555-565, 2021.
R. E. Amariglio, Buckley, R. F., Rabin, J. S., Papp, K. V., Quiroz, Y. T., Mormino, E. C., Sparks, K. P., Johnson, K. A., Rentz, D. M., and Sperling, R. A., Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study., J Alzheimers Dis, vol. 75, no. 4, pp. 1437-1446, 2020.
H. An, Choi, B., Park, K. - W., Kim, D. - H., Yang, D. - W., Hong, C. Hyung, Kim, S. Yoon, and Han, S. - H., The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects., J Alzheimers Dis, vol. 55, no. 2, pp. 727-735, 2017.
D. Arnaldi, Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S., Famá, F., Terzaghi, M., Girtler, N., Brugnolo, A., Doglione, E., Pardini, M., Villani, F., and Nobili, F., Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study., J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
D. Asaoka, Xiao, J., Takeda, T., Yanagisawa, N., Yamazaki, T., Matsubara, Y., Sugiyama, H., Endo, N., Higa, M., Kasanuki, K., Ichimiya, Y., Koido, S., Ohno, K., Bernier, F., Katsumata, N., Nagahara, A., Arai, H., Ohkusa, T., and Sato, N., Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial., J Alzheimers Dis, vol. 88, no. 1, pp. 75-95, 2022.
E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex., J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.
I. Baghallab, Reyes-Ruiz, J. Mauricio, Abulnaja, K., Huwait, E., and Glabe, C., Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8., J Alzheimers Dis, vol. 66, no. 3, pp. 1235-1244, 2018.
S. Baker, Polanco, J. Carlos, and Götz, J., Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice., J Alzheimers Dis, vol. 54, no. 3, pp. 1207-1217, 2016.
J. E. Baker, Lim, Y. Ying, Jaeger, J., Ames, D., Lautenschlager, N. T., Robertson, J., Pietrzak, R. H., Snyder, P. J., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P., Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease., J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Papa, R., Postacchini, D., and Conti, F., Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 1, pp. 37-43, 2017.
K. J. Bangen, Thomas, K. R., Sanchez, D. L., Edmonds, E. C., Weigand, A. J., Delano-Wood, L., and Bondi, M. W., Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults., J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
A. A. Diaz Baquero, Franco-Martín, M. A., Vidales, E. Parra, Toribio-Guzmán, J. Miguel, Bueno-Aguado, Y., Abad, F. Martínez, Bartolomé, M. V. Perea, Asl, A. Mahmoudi, and van der Roest, H. G., The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment., J Alzheimers Dis, vol. 86, no. 2, pp. 711-727, 2022.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals., J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
M. Berger, Nadler, J. W., Friedman, A., McDonagh, D. L., Bennett, E. R., Cooter, M., Qi, W., Laskowitz, D. T., Ponnusamy, V., Newman, M. F., Shaw, L. M., Warner, D. S., Mathew, J. P., and James, M. L., The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial., J Alzheimers Dis, vol. 52, no. 4, pp. 1299-310, 2016.
A. Katrine Bergland, Dalen, I., Larsen, A. Inge, Aarsland, D., and Soennesyn, H., Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia., J Alzheimers Dis, vol. 56, no. 2, pp. 575-584, 2017.
A. Katrine Bergland, Proitsi, P., Kirsebom, B. - E., Soennesyn, H., Hye, A., Larsen, A. Inge, Xu, J., Legido-Quigley, C., Rajendran, L., Fladby, T., and Aarsland, D., Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease., J Alzheimers Dis, vol. 77, no. 3, pp. 1117-1127, 2020.
A. H. Betrie, Ayton, S., Bush, A. I., Angus, J. A., Lei, P., and Wright, C. E., Evidence of a Cardiovascular Function for Microtubule-Associated Protein Tau., J Alzheimers Dis, vol. 56, no. 2, pp. 849-860, 2017.
C. M. Black, Fillit, H., Xie, L., Hu, X., M Kariburyo, F., Ambegaonkar, B. M., Baser, O., Yuce, H., and Khandker, R. K., Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 185-193, 2018.
V. Bloniecki, Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., and Freund-Levi, Y., Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid., J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
M. Boada, Anaya, F., Ortiz, P., Olazarán, J., Shua-Haim, J. R., Obisesan, T. O., Hernandez, I., Muñoz, J., Buendia, M., Alegret, M., Lafuente, A., Tárraga, L., Núñez, L., Torres, M., Grifols, J. Ramon, Ferrer, I., Lopez, O. L., and Páez, A., Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial., J Alzheimers Dis, vol. 56, no. 1, pp. 129-143, 2017.
L. Bonanni, Franciotti, R., Nobili, F., Kramberger, M. G., Taylor, J. - P., Garcia-Ptacek, S., N Falasca, W., Famá, F., Cromarty, R., Onofrj, M., and Aarsland, D., EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study., J Alzheimers Dis, vol. 54, no. 4, pp. 1649-1657, 2016.
S. Bouges, Fischer, B., Norton, D. L., Wyman, M. F., Lambrou, N., Zuelsdorff, M., Van Hulle, C. A., Ennis, G. E., James, T. T., Johnson, A. L., Chin, N., Carlsson, C. M., and Gleason, C. E., Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups., J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.